Abstract
Purpose
This study was designed to investigate the safety and efficacy of the circumferential clip-based (StarClose) vascular closure device (VCD) in coagulopathic and cirrhotic patients with hepatocellular carcinoma (HCC) after doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE).
Methods
Consecutive cirrhotic patients with HCC, who underwent DEB TACE from November 2009 to February 2012, were included in the study. Based on platelet count (PC) and international normalized ratio (INR), these patients were further divided into group A (PC ≥ 150 k/dl), B (PC = 50–149 k/dl), C (PC < 50 k/dl), D (INR ≤ 1.2), E (INR = 1.21–1.5), and F (INR > 1.5). StarClose VCD was attempted in each case. Technical success was defined as complete hemostasis achieved within 3 min after the closure. Periprocedural complications were studied.
Results
A total of 350 DEB TACEs were performed in 195 patients (mean age 61.6 years, SD 9.1). StarClose VCD was attempted in all cases. StarClose device was not deployed in 2.2 % (8/350) of cases due to improper femoral punctures and severe atherosclerotic disease. Technical success rate was 97.1 % (332/342). All groups (A–F) were similar in age, sex, body mass index, and technical success rate (P > 0.05). Minor complications occurred after 1.8 % (6/342) of cases. VCD was repeatedly used in 92 patients with 96.2 % (230/239) of technical success rate. There was no major complication related to VCD. There was no access site infection, leg ischemia, and pseudoaneurysm or symptomatic groin hematoma.
Conclusions
Circumferential clip based (StarClose) arterial closure device achieved effective and rapid hemostasis after DEB TACE with minimal complications in cirrhotic patients with HCC and coagulopathy. StarClose deployment and reaccess in patients with PC < 50 k/dl and INR > 1.2 are safe and effective.
Similar content being viewed by others
References
Lammer J, Malagari K, Vogl T et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Interv Radiol 33(1):41–52
Malagari K, Chatzimichael K, Alexopoulou E et al (2008) Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Interv Radiol 31(2):269–280
Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS (2010) Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC). J Surg Oncol 101(6):476–480
Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359(9319):1734–1739
Prajapati H, Spivey J, Hanish S et al (2012) mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE). Ann Oncol 24(4):965–973
Prajapati HJ, Dhanasekaran R, El-Rayes BF et al (2013) Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma. J Vasc Interv Radiol 24:307–315
Prajapati HJ, Rafi S, El-Rayes BF, Kauh JS, Kooby DA, Kim HS (2012) Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization. J Vasc Interv Radiol 23(10):1286–1293 e1281
Pluta A, Gutkowski K, Hartleb M (2010) Coagulopathy in liver diseases. Adv Med Sci 55(1):16–21
Hoffer EK, Bloch RD (2003) Percutaneous arterial closure devices. J Vasc Interv Radiol 14(7):865–885
Sanborn TA, Gibbs HH, Brinker JA, Knopf WD, Kosinksi EJ, Roubin GS (1999) A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Invasive Cardiol 11(Suppl B):6B–13B
Kahn ZM, Kumar M, Hollander G, Frankel R (2002) Safety and efficacy of the Perclose suture-mediated closure device after diagnostic and interventional catheterizations in a large consecutive population. Catheter Cardiovasc Interv 55(1):8–13
Hieb R, Neisen M, Hohenwalter E, Molnar J, Rilling W (2008) Safety and effectiveness of repeat arterial closure using the AngioSeal device in patients with hepatic malignancy. J Vasc Intervent Radiol 19(12):1704–1708
Jaff MR, Hadley G, Hermiller JB et al (2006) The safety and efficacy of the StarClose vascular closure system: the ultrasound substudy of the CLIP study. Catheter Cardiovasc Interv 68(5):684–689
Hermiller JB, Simonton C, Hinohara T et al (2006) The StarClose vascular closure system: interventional results from the CLIP study. Catheter Cardiovasc Interv 68(5):677–683
Branzan D, Sixt S, Rastan A et al (2009) Safety and efficacy of the StarClose vascular closure system using 7-F and 8-F sheath sizes: a consecutive single-center analysis. J Endovasc Ther 16(4):475–482
Desideri A, Tonello D, Coscarelli S, Alitto F, Daniotti A, Chioin R (2005) Early mobilization after percutaneous catheterization and vascular closure with a novel device (Star-Close). Am J Cardiol 96(10):1408–1409
Deuling JH, Vermeulen RP, Anthonio RA et al (2008) Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression. Catheter Cardiovasc Interv 71(4):518–523
Spiliopoulos S, Katsanos K, Karnabatidis D, Diamantopoulos A, Nikolaos C, Siablis D (2011) Safety and efficacy of the StarClose vascular closure device in more than 1,000 consecutive peripheral angioplasty procedures. J Endovasc Ther 18(3):435–443
Hermiller J, Simonton C, Hinohara T et al (2005) Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization. J Invasive Cardiol 17(10):504–510
Imam A, Carter RM, Phillips-Hughes J, Boardman P, Uberoi R (2007) StarClose vascular closure device: prospective study on 222 deployments in an interventional radiology practice. Cardiovasc Intervent Radiol 30(4):738–742
Ratnam LA, Raja J, Munneke GJ, Morgan RA, Belli A-M (2007) Prospective nonrandomized trial of manual compression and Angio-Seal and Starclose arterial closure devices in common femoral punctures. Cardiovasc Intervent Radiol 30(2):182–188
Ruygrok PN, Ormiston JA, Stewart JT et al (2005) Initial experience with a new femoral artery closure device following percutaneous coronary intervention with glycoprotein IIb/IIIa inhibition. Catheter Cardiovasc Interv 66(2):185–191
Tay EL, Co M, Tai BC et al (2008) Clinical experience of StarClose vascular closure device in patients with first and recurrent femoral punctures. J Interv Cardiol 21(1):67–73
Gaba R, Parvinian A, Trinos E (2012) Safety and efficacy of StarClose SE vascular closure system in high-risk liver interventional oncology patients. J Vasc Access 13(4):415–420
National Cancer Institute 2009 Common terminology criteria for adverse events (CTCAE) version 4, United States Department of Health and Human Services, Editor. Available: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed 22 Feb 2012
Bashour FN, Teran JC, Mullen KD (2000) Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol 95(10):2936–2939
Lechner K, Niessner H, Thaler E (1977) Coagulation abnormalities in liver disease. Semin Thromb Hemost 4(1):40–56
Green G, Poller L, Thomson JM, Dymock IW (1976) Factor VII as a marker of hepatocellular synthetic function in liver disease. J Clin Pathol 29(11):971–975
Patel T (1999) Surgery in the patient with liver disease. Mayo Clin Proc 74(6):593–599
Friedman LS (1999) The risk of surgery in patients with liver disease. Hepatology 29(6):1617–1623
Michalis LK, Rees MR, Patsouras D et al (2002) A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal and Duett). Cardiovasc Intervent Radiol 25(5):423–429
Ansel G, Yakubov S, Neilsen C et al (2006) Safety and efficacy of staple-mediated femoral arteriotomy closure: results from a randomized multicenter study. Catheter Cardiovasc Interv 67(4):546–553
Nader RG, Garcia JC, Drushal K, Pesek T (2002) Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures. J Invasive Cardiol 14(6):305–307
Palmer BL, Gantt DS, Lawrence ME, Rajab MH, Dehmer GJ (2004) Effectiveness and safety of manual hemostasis facilitated by the SyvekPatch with one hour of bedrest after coronary angiography using six-French catheters. Am J Cardiol 93(1):96–97
Kim MC (2006) Vascular closure devices. Cardiol Clin 24(2):277–286 vii
Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M (2004) Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA 291(3):350–357
Nikolsky E, Mehran R, Halkin A et al (2004) Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 44(6):1200–1209
Dangas G, Mehran R, Kokolis S et al (2001) Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol 38(3):638–641
Sohail MR, Khan AH, Holmes DR Jr, Wilson WR, Steckelberg JM, Baddour LM (2005) Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc 80(8):1011–1015
Wang DS, Chu LF, Olson SE et al (2008) Comparative evaluation of noninvasive compression adjuncts for hemostasis in percutaneous arterial, venous, and arteriovenous dialysis access procedures. J Vasc Interv Radiol 19(1):72–79
McTaggart RA, Raghavan D, Haas RA et al (2010) StarClose Vascular closure device: safety and efficacy of deployment and reaccess in a neurointerventional radiology service. Am J Neuroradiol 31:1148–1150
Gray BH, Miller R, Langan EM et al (2009) The utility of the StarClose arterial closure device in patients with peripheral arterial disease. Ann Vasc Surg 23:341–344
Li X, Wang Z, Chen J et al (2013) Safety and effectiveness of repeat arterial closure using the StarClose vascular closure device in patients with hepatic malignancy. Clin Radiol S0009–9260(13):00153
Kirchhof C, Schickel S, Schmidt-Lucke C, Schmidt-Lucke JA (2002) Local vascular complications after use of the hemostatic puncture closure device Angio-Seal. Vasa 31(2):101–106
Wille J, Vos JA, Overtoom TT, Suttorp MJ, van de Pavoordt ED, de Vries JP (2006) Acute leg ischemia: the dark side of a percutaneous femoral artery closure device. Ann Vasc Surg 20(2):278–281
Durack JC, Thor Johnson D, Fidelman N, Kerlan RK, LaBerge JM (2012) Entrapment of the StarClose vascular closure system after attempted common femoral artery deployment. Cardiovasc Intervent Radiol 35(4):942–944
Gonsalves M, Walkden M, Belli AM (2008) Laceration of the common femoral artery following deployment of the Starclose vascular closure system. Cardiovasc Intervent Radiol 31(4):817–820
Castelli P, Caronno R, Piffaretti G, Tozzi M, Lomazzi C (2006) Incidence of vascular injuries after use of the Angio-Seal closure device following endovascular procedures in a single center. World J Surg 30(3):280–284
Mukhopadhyay K, Puckett MA, Roobottom CA (2005) Efficacy and complications of Angioseal in antegrade puncture. Eur J Radiol 56(3):409–412
Conflict of interest
Hasmukh J. Prajapati, MD, Shoaib Rafi, MBBS, Faramarz, Edalat MD, David A. Kooby, MD, and Hyun S. Kim, MD has nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prajapati, H.J., Rafi, S., Edalat, F. et al. Safety and Efficacy of a Circumferential Clip-Based Vascular Closure Device in Cirrhotic and Coagulopathic Patients with Hepatocellular Carcinoma After Doxorubicin Drug-eluting Beads Transarterial Chemoembolization. Cardiovasc Intervent Radiol 37, 664–670 (2014). https://doi.org/10.1007/s00270-013-0709-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-013-0709-9